Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Nerve growth factor - Genentech

Next Previous
Search
Drug Profile

Nerve growth factor - Genentech

Alternative Names: Neuleze

Latest Information Update: 25 Sep 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Amgen Boulder; Chiron Corporation; Genentech
  • Class Foot disorder therapies; Nerve growth factors; Neuroprotectants
  • Mechanism of Action Neuron stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alzheimer's disease; Diabetic neuropathies; Herpes simplex virus infections; Neuropathic pain; Peripheral nervous system diseases

Most Recent Events

  • 30 Jan 2004 No development reported - Clinical-Phase-Unknown for Alzheimer's disease in Japan (unspecified route)
  • 30 Jan 2004 No development reported - Clinical-Phase-Unknown for Alzheimer's disease in Sweden (unspecified route)
  • 30 Jan 2004 No development reported - Preclinical for Herpes simplex virus infections in USA (unspecified route)

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top